News Release

Atrial fibrillation hospitalizations, costs soar in United States

Abstract 19107 (Room D170)

Peer-Reviewed Publication

American Heart Association

U.S. hospitalizations and costs of care for atrial fibrillation nearly doubled from 1998 to 2010, according to research presented

at the American Heart Association's Scientific Sessions 2013.

Over 4.6 million hospitalizations occurred nationwide for atrial fibrillation during the decade, said researchers who found the progressive percentage increase reached 46 percent.

Researchers projected a similar trend in hospitalizations and costs over the next decade and concluded that 541,000 hospitalizations can be expected by 2020, a 28 percent relative increase from 2010.

Atrial fibrillation is a quivering or irregular heartbeat that can lead to blood clots, stroke, heart failure and other heart-related complications.

Using the Nationwide Inpatient Sample database, researchers estimate the cost of hospitalizations to rise by 55 percent in 2020 compared to the cost of care in 2010.

"Atrial fibrillation has increased tremendously over the last decade and is likely to pose a large public health burden in the future," said Sadip Pant, M.D., lead researcher of the study.

An estimated 2.7 million Americans are living with atrial fibrillation.

###

For more news from AHA Scientific Sessions 2013 follow us on Twitter @HeartNews #AHA13.

Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at http://www.heart.org/corporatefunding.

Additional resources related to these tips are on the right column of the release link at http://newsroom.heart.org/news/monday-news-tips-2563028?preview=33a9c0eba00d53ad8e2e23fa06f34915.

NOTE: ALL TIMES ARE CENTRAL. ALL TIPS ARE EMBARGOED UNTIL THE TIME OF PRESENTATION OR 3 P.M. CT/4 P.M. ET EACH DAY, WHICHEVER COMES FIRST. For more information Nov. 16-20, call the AHA News Media Staff Office in the Dallas Convention Center at (214) 853-8008. Before or after these dates, call the Communications Office in Dallas at (214) 706-1173. For public inquiries, call (800) AHA-USA1 (242-8721).


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.